EVISTA Film-coated tablet Ref.[10560] Active ingredients: Raloxifene

Source: FDA, National Drug Code (US)  Revision Year: 2020 

Product description

EVISTA (raloxifene hydrochloride) is an estrogen agonist/antagonist, commonly referred to as a selective estrogen receptor modulator (SERM) that belongs to the benzothiophene class of compounds.

The chemical structure is:

The chemical designation is methanone, [6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl][4[2-(1-piperidinyl)ethoxy]phenyl]-, hydrochloride. Raloxifene hydrochloride (HCl) has the empirical formula C28H27NO4S•HCl, which corresponds to a molecular weight of 510.05. Raloxifene HCl is an off-white to pale-yellow solid that is very slightly soluble in water.

EVISTA is supplied in a tablet dosage form for oral administration. Each EVISTA tablet contains 60 mg of raloxifene HCl, which is the molar equivalent of 55.71 mg of free base. Inactive ingredients include anhydrous lactose, carnauba wax, crospovidone, FD&C Blue No. 2 aluminum lake, hypromellose, lactose monohydrate, magnesium stearate, modified pharmaceutical glaze, polyethylene glycol, polysorbate 80, povidone, propylene glycol, and titanium dioxide.

Dosage Forms and Strengths

60 mg, white, elliptical, film-coated tablets (not scored) imprinted with either 4165 or LILLY 4165 on one side in edible blue ink.

How Supplied

EVISTA 60 mg tablets are white, elliptical, film coated (not scored) and imprinted with either 4165 or LILLY 4165 on one side in edible blue ink. They are available as follows:

Tablet ImprintLILLY
4165
4165
Presentations and NDCs
Bottles of 30 (unit of use) 0002-4165-30 0002-4184-30
Bottles of 100 (unit of use) 0002-4165-02 0002-4184-02
Bottles of 2000 0002-4165-07 0002-4184-07

Marketed by: Lilly USA, LLC, Indianapolis, IN 46285, USA

Drugs

Drug Countries
EVISTA Austria, Australia, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, United Kingdom, United States, South Africa

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.